Evidence map›Paper›PMID 19710673›Full record

ArticleNature reviews. Rheumatology2009

Resolution of pansclerotic morphea after treatment with antithymocyte globulin.

Philip Song, Christopher Gocke, Fredrick M Wigley, Francesco Boin

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Nature reviews. Rheumatology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Philip SongDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Christopher Gocke
Fredrick M Wigley
Francesco Boin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA previously healthy 50-year-old man presented with thickening and hardening of the skin on his trunk, neck and upper extremities that had started after the appearance of a 5 cm web-like patch of blood vessels on his upper chest and progressed over 4 months. He also reported difficulties with swallowing and a 20 kg weight loss. INVESTIGATIONS: Physical examination, laboratory testing, including complete blood count, autoimmune serology for antiplatelet, antinuclear and extractable nuclear antibodies, direct antiglobulin test, incisional skin biopsy, bone-marrow biopsy, and MRI of the upper extremities. DIAGNOSIS: Pansclerotic morphea associated with red cell aplasia and immune-mediated thrombocytopenia. MANAGEMENT: Treatment with prednisone 60 mg per day and methotrexate 15 mg per week was started, but symptoms worsened. Methotrexate was replaced by pulsed intravenous methylprednisolone (1 g daily for 3 days), followed by mycophenolate mofetil started at 1 g per day and titrated up over 4 weeks to 3 g per day. Severe bicytopenia developed that did not improve with an 8-week washout of immunosuppressive agents. His fibrotic skin and hematologic conditions dramatically responded to antithymocyte globulin 40 mg/kg daily for 4 days, plus 10 mg/kg ciclosporin and methylprednisolone 1 mg/kg per day.

Indexed as

Antilymphocyte SerumBone Marrow CellsCyclosporineDermatologic AgentsDrug Therapy, CombinationGlucocorticoidsHumansImmunosuppressive AgentsMaleMethylprednisoloneMiddle AgedRed-Cell Aplasia, PureRemission InductionScleroderma, LocalizedTreatment OutcomeAntilymphocyte SerumCyclosporineDermatologic AgentsGlucocorticoidsImmunosuppressive AgentsMethylprednisolone

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.